文献速递皮肤肿瘤

多样化初级保健人群中黑色素瘤风险MC1R检测的兴趣与采纳:一项随机临床试验

Interest and Uptake of MC1R Testing for Melanoma Risk in a Diverse Primary Care Population: A Randomized Clinical Trial.
PubMed 文献 · JAMA Dermatol · 2018-01-01

该随机临床试验在新墨西哥大学普通内科诊所的患者中,评估了普通人群对MC1R检测的兴趣与采纳情况。499名参与者中,232人(46%)登录网站了解检测,204人(88%)请求检测,167人(82%)寄回试剂盒。种族/族裔和教育程度是登录网站的最强预测因素,晒伤史是请求检测的最强预测因素。

要点

  • 在多样化初级保健人群中,对MC1R检测的兴趣和采纳率中等偏高。
  • 西班牙裔相比非西班牙裔白人登录网站了解检测的比值比为0.5(95% CI 0.3-0.7)。
  • 有晒伤史者请求检测的比值比为5.4(95% CI 2.3-12.9)。

核心结论

  • 在这一多样化样本中,对MC1R检测的兴趣和采纳率处于中等偏高水平。

研究设计与样本

  • 随机临床试验,纳入新墨西哥大学普通内科诊所的499名随机分配到MC1R检测邀请组的参与者。

主要发现

  • 499名参与者中,232人(46%)登录网站了解MC1R检测;登录者中204人(88%)决定请求检测;请求检测者中167人(82%)寄回试剂盒。
  • 登录网站的最强预测因素为种族/族裔和教育程度:西班牙裔 vs 非西班牙裔白人的比值比为0.5(95% CI 0.3-0.7);高中以上 vs 高中或以下的比值比为2.7(95% CI 1.7-4.3)。
  • 请求检测的最强预测因素为晒伤史:有晒伤史 vs 无晒伤史的比值比为5.4(95% CI 2.3-12.9)。

临床怎么用

  • 随着基因组信息融入普通人群的精准皮肤癌预防,作者认为可能需要解决检测的潜在障碍。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Germline variants in the MC1R gene are common and confer moderate melanoma risk in those with varied skin types. Approaches to precision skin cancer prevention that include genetic information may promote risk awareness and risk reduction in the general population, including Hispanics. OBJECTIVE: To examine prevalence of interest in and uptake of MC1R testing in the general population and examine patterns across demographic and skin cancer risk factors. DESIGN, SETTING, AND PARTICIPANTS: A randomized clinical trial examined interest in and uptake of MC1R testing among patients at University of New Mexico General Internal Medicine clinics. Study participants were randomized to either a usual-care condition (National Cancer Institute skin cancer pamphlet for diverse skin types) or an MC1R test offer. Participants were registered clinic patients (≥6 months) and English or Spanish fluent. Of the 600 participants recruited to the overall trial, the present study included those 499 participants randomized to the MC1R test offer. INTERVENTIONS: Participants were presented with the option to log onto the study website to read 3 educational modules presenting the rationale, benefits, and drawbacks of MC1R testing. MAIN OUTCOMES AND MEASURES: Main outcomes include website log on (yes vs no), saliva test kit request (yes vs no), and saliva test kit return for MC1R testing (yes vs no). Demographic and skin cancer risk factors were examined as potential predictors of test interest and uptake. RESULTS: Of the 499 participants (220 [44%] non-Hispanic white, 242 [48%] Hispanic, 396 [79%] female; mean [SD] age, 54 [14.3] years), 232 (46%) elected to learn about MC1R testing by logging onto the website; 204 (88%) of those who logged on decided to request testing; and 167 (82%) of those who requested testing returned the kit. The strongest predictors of website log on were race/ethnicity and education (non-Hispanic whites were more likely to log on [odds ratio for Hispanics vs non-Hispanic whites, 0.5; 95% CI, 0.3-0.7], as were more highly educated individuals [odds ratio for more than high school vs high school or less, 2.7; 95% CI, 1.7-4.3]). The strongest predictor of ordering the test was sunburn history (odds ratio, 5.4; 95% CI, 2.3-12.9 vs no sunburn history). CONCLUSIONS AND RELEVANCE: There were moderately high levels of MC1R test interest and uptake in this diverse sample. Addressing potential barriers to testing may be warranted as genomic information becomes integrated into general population approaches to the precision prevention of skin cancer. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT03130569.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Hay JL, Zielaskowski K, Meyer White K, et al. Interest and Uptake of MC1R Testing for Melanoma Risk in a Diverse Primary Care Population: A Randomized Clinical Trial. JAMA Dermatol. 2018. PMID: 29801061. doi:10.1001/jamadermatol.2018.0592

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。